A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy
Clinical trial NCT02469688 · COMPLETED
Trial details
- NCT number
- NCT02469688
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-18
- Primary completion
- 2015-11-27
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.